Citius Oncology Income Statement (2021-2025) | CTOR

Income Statement Dec2021 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 3.94M
Cost of Revenue (Quarter) 0.79M
Gross Profit (Quarter) 3.15M
Operating items
Research & Development (Quarter) 1.15M1.35M1.13M1.26M3.14M0.94M1.08M1.02M
Selling, General & Administrative (Quarter) 0.15M0.20M0.42M1.52M1.39M1.54M3.32M2.24M1.88M1.34M2.86M
Restructuring Costs (Quarter) 0.03M0.03M0.03M0.42M0.43M0.47M0.57M0.57M0.57M0.50M0.50M
Other Operating Expenses (Quarter) 1.49M1.52M1.48M1.24M1.52M1.56M1.80M4.03M
Operating Expenses (Quarter) 0.18M0.23M0.45M4.58M4.69M4.63M6.39M7.47M4.94M4.71M8.41M
Operating Income (Quarter) -0.15M-0.20M-0.42M-0.27M-4.63M-6.39M-4.94M-4.71M-5.25M
EBIT (Quarter) -0.15M-0.20M-0.42M-4.58M-0.27M-4.63M-6.39M-7.47M-4.94M-4.71M-5.25M
Non-operating items
Interest & Investment Income (Quarter) 0.03M
Non Operating Income (Quarter) 0.76M0.82M0.58M0.76M0.64M-0.02M
Net income details
EBT (Quarter) -0.15M-0.20M-0.42M-4.58M-4.69M-4.63M-6.39M-7.47M-5.11M-4.73M-5.27M
Tax Provisions (Quarter) 0.14M0.14M0.14M0.26M0.26M0.26M0.26M0.26M
Profit After Tax (Quarter) 0.61M0.62M0.16M-4.73M-4.84M-4.77M-6.66M-7.74M-5.37M-5.00M-5.53M
Income from Continuing Operations (Quarter) -0.15M-0.20M-0.42M-4.73M-4.84M-4.77M-6.66M-7.74M-5.37M-5.00M-5.53M
Consolidated Net Income (Quarter) -0.15M-0.20M-0.42M-4.73M-4.84M-4.77M-6.66M-7.74M-5.37M-5.00M-5.53M
Income towards Parent Company (Quarter) -0.15M-0.20M-0.42M-4.73M-4.84M-4.77M-6.66M-7.74M-5.37M-5.00M-5.53M
Net Income towards Common Stockholders (Quarter) -0.15M-0.20M-0.42M-4.73M-4.84M-4.77M-6.66M-7.74M-5.37M-5.00M-5.53M
Additional items
EPS (Basic) (Quarter) 0.070.070.02-0.07-0.07-0.07-0.09-0.11-0.08-0.06-0.06
EPS (Weighted Average and Diluted) (Quarter) 0.070.070.02-0.07-0.07-0.07-0.09-0.11-0.08-0.06-0.06
Shares Outstanding (Weighted Average) (Quarter) 1.73M1.50M1.34M6.60M6.60M67.50M67.50M4.74M67.50M68.05M71.55M71.55M71.55M13.28M87.46M
Shares Outstanding (Diluted Average) (Quarter) 1.50M1.34M6.60M6.60M67.50M67.50M67.50M67.50M68.05M71.55M71.55M71.55M73.27M87.46M
EBITDA (Quarter) -0.15M-0.20M-0.42M-4.58M-0.27M-4.63M-6.39M-7.47M-4.94M-4.71M-5.25M
Interest Expenses (Quarter) 0.16M0.06M0.05M
Tax Rate (Quarter) -3.14%-3.07%-3.11%-4.13%-3.54%-5.18%-5.58%-5.01%